Corrigendum to "SELNET Clinical Practice Guidelines for Soft Tissue Sarcoma and GIST" [cancer Treat. Rev. 102 (2021) 102312].

The authors regret, the author affiliation “IRCCS Istituto Ortopedico Rizzoli, University of Bologna, Via Pupilli, 1, 40136 Bologna, Italy” reported in the article is not correct. The correct affiliation, applicable to the following authors, is as updated above. The authors would like to apologise for any inconvenience caused. SELNET clinical practice guidelines for soft tissue sarcoma and GISTCancer Treatment ReviewsVol. 102PreviewSoft tissue sarcoma (STS) is a heterogeneous group of neoplasms, encompassing > 80 different histologic subtypes. Approximately three quarter of sarcoma arise from soft-tissue, about 15% are gastrointestinal stromal tumours (GISTs) and bone sarcoma represent the remaining 10%. The current guidelines will focus on soft-tissue and GIST, excluding Kaposi sarcoma and non-pleomorphic rhabdomyosarcoma. Bone sarcomas are covered in a different paper. Full-Text PDF Open Access